(S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid
TL;DR: (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid (CAS 956046-87-0) is a chemical compound with molecular formula C23H27NO6 and molecular weight 413.18 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
(2S)-4-methyl-2-[[2-(2,3,5,9-tetramethyl-7-oxofuro[3,2-g]chromen-6-yl)acetyl]amino]pentanoic acid
Also Known As: (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid, N-[(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetyl]-L-leucine, (2S)-4-methyl-2-[[2-(2,3,5,9-tetramethyl-7-oxofuro[3,2-g]chromen-6-yl)acetyl]amino]pentanoic acid
| Molecular Formula | C23H27NO6 |
|---|---|
| Molecular Weight | 413.18 g/mol |
| LogP | 3.93088 |
| Topological Polar Surface Area | 109.75 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Exact Mass | 413.18384 |
| Heavy Atoms | 30 |
| Complexity | 1214.3575 |
Chemical Identifiers
| CAS Number | 956046-87-0 |
|---|---|
| SMILES | CC1=C(OC2=C(C3=C(C=C12)C(=C(C(=O)O3)CC(=O)N[C@@H](CC(C)C)C(=O)O)C)C)C |
Product Overview
(S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid (CAS 956046-87-0), with molecular formula C23H27NO6 and molecular weight 413.18 g/mol. IUPAC: (2S)-4-methyl-2-[[2-(2,3,5,9-tetramethyl-7-oxofuro[3,2-g]chromen-6-yl)acetyl]amino]pentanoic acid.
Chemical Property Profile of (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid
Property Insights of (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid
The XLogP value of 3.93088 indicates that (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 109.75 Ų falls within the moderate polarity range, balancing permeability and solubility for (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid. Following Lipinski's Rule of Five, (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid has 2 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid?
The CAS number of (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid is 956046-87-0.
What is the molecular formula of (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid?
The molecular formula of (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid is C23H27NO6.
What is the molecular weight of (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid?
The molecular weight of (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid is 413.18 g/mol.
Where can I buy (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid?
You can request a quote for (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid?
Yes, KEHONG BIO provides custom synthesis services for (S)-4-methyl-2-(2-(2,3,5,9-tetramethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamido)pentanoic acid and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.